AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
TL;DR
This review comprehensively summarizes recent advances in brain organoid technology and its applications in modelling AD and PD and represents a transformative platform for studying the pathogenesis of neurodegenerative diseases and accelerating translational neuroscience.
This review focuses on exosome-derived proteins and small non-coding RNAs as promising non-invasive biomarkers for stroke, PD, and AD, given the accessibility and stability of exosomes in biological fluids, and examines their potential diagnostic and therapeutic relevance.
Both the therapeutic promise and the realistic limitations of siRNA-based approaches for AD are discussed, priorities for future development are outlined, and key gaps that must be addressed are identified to enable meaningful clinical implementation.
This review traces the historical evolution of regenerative therapies for NDDs - from early exploratory cell transplantation to modern approaches involving pluripotent stem cells (PSCs) and in vivo direct reprogramming and elucidate the core strategies of regenerative medicine within an integrated framework encompassin...
This review offers a framework for prioritizing organoid applications in PD research and translation by distinguishing established findings from emerging technologies and providing a realistic assessment of current limitations.
Efforts to develop sophisticated computational modeling of intranasal drug delivery, including computational fluid dynamics (CFD) deposition and physiologically based pharmacokinetics (PBPK) modeling, also continue to advance the intranasal drug delivery research and potentially improve the feasibility of developing cl...
Overall, organoid technology represents a promising approach for precision medicine, personalized therapy, and next-generation drug development and continued development of standardized culture systems and multicellular organoid platforms may improve reproducibility and regulatory acceptance.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.